Finch Therapeutics Group Inc
General ticker "FNCH" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $18.7M
Finch Therapeutics Group Inc follows the US Stock Market performance with the rate: 38.9%.
Estimated limits based on current volatility of 3.8%: low 10.22$, high 11.04$
Factors to consider:
- Current price 43.0% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.17$, 7.55$]
- 2024-12-30 to 2025-12-30 estimated range: [2.01$, 6.57$]
Financial Metrics affecting the FNCH estimates:
- Negative: Non-GAAP EPS, $ of -23.35 <= 0.10
- Negative: Operating profit margin, % of -99.69 <= 1.03
- Negative: Operating cash flow per share per price, % of -84.21 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Interest expense per share, $ of 0 <= 0
Short-term FNCH quotes
Long-term FNCH plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $18.53MM | $0.86MM | $0.11MM |
| Operating Expenses | $78.52MM | $116.45MM | $34.11MM |
| Operating Income | $-59.98MM | $-115.59MM | $-34.00MM |
| Non-Operating Income | $1.82MM | $0.95MM | $-44.21MM |
| Interest Expense | $0.00MM | $35.44MM | $0.00MM |
| R&D Expense | $57.28MM | $57.89MM | $7.20MM |
| Income(Loss) | $-58.16MM | $-114.65MM | $-78.22MM |
| Taxes | $0.00MM | $0.00MM | $-3.46MM |
| Profit(Loss) | $-58.16MM | $-114.65MM | $-74.75MM |
| Stockholders Equity | $202.22MM | $95.71MM | $22.89MM |
| Inventory | $9.07MM | $3.51MM | $0.00MM |
| Assets | $225.37MM | $162.94MM | $55.37MM |
| Operating Cash Flow | $-67.13MM | $-74.85MM | $-31.50MM |
| Capital expenditure | $15.98MM | $2.18MM | $0.00MM |
| Investing Cash Flow | $-15.92MM | $-2.18MM | $1.33MM |
| Financing Cash Flow | $119.11MM | $14.87MM | $-16.16MM |
| Earnings Per Share* | $-35.27 | $-71.52 | $-46.59 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.